Shanghai, China

Yongcong Lv

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: A Spotlight on Inventor Yongcong Lv from Shanghai, CN

Introduction

Yongcong Lv is a notable inventor based in Shanghai, China, recognized for his contributions to the field of medicinal chemistry. With a total of three patents to his name, he has made significant strides in the development of innovative compounds with potential medical applications.

Latest Patents

Among his most recent patents is the "Phthalazinone compound, and preparation method therefor and medical use thereof." This invention discloses a novel phthalazinone compound, a preparation method for this compound, and its medical uses. Specifically, the patent describes a compound represented by a particular formula, along with its pharmacodynamically acceptable salt. The compound is noted for its potential use in the degradation of androgen receptors (AR).

Career Highlights

Yongcong Lv has held positions at prestigious institutions, including the Shanghai Institute of Materia Medica and the Chinese Academy of Sciences. His work at these esteemed organizations has allowed him to further his research and development efforts in medicinal compounds, particularly in areas related to pharmacology and therapeutic applications.

Collaborations

Throughout his career, Yongcong has collaborated with prominent researchers, including Hongfu Lu and Weiqiang Xing. These collaborations have fostered an exchange of ideas and innovation, enhancing the potential impact of their research on the scientific community.

Conclusion

Yongcong Lv continues to be a significant figure in the realm of medicinal chemistry, with his innovative approaches and patented inventions paving the way for advancements in medical treatments. His work exemplifies the importance of dedication and collaboration in driving innovation forward.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…